Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Selecting Anti-Melanoma Drug Targets

Posted on August 28th, 2017 by in Pharma R&D

Every year, hundreds of thousands of people are diagnosed with melanoma, the most deadly form of skin cancer. Although rates of melanoma have continued to rise over the last three decades Continue reading “Selecting Anti-Melanoma Drug Targets” »

Cancer Immunotherapy Webinar on September 12: Register Now

Posted on August 25th, 2017 by in Pharma R&D

After decades of being treated with a fairly typical combination of surgery and therapies, cancer is now being met with exciting new treatments that are more targeted and often less hard on the patient. Continue reading “Cancer Immunotherapy Webinar on September 12: Register Now” »

Emerging Oncology Drugs in Pharma R&D Pipeline

Posted on March 2nd, 2017 by in Pharma R&D

Cancer. It’s the 2nd leading cause of death in this country (1), and a disease feared by patients and healthcare professionals alike. Today’s cancer treatments vary in nature, and also, efficacy and levels of side effect profiles. Continue reading “Emerging Oncology Drugs in Pharma R&D Pipeline” »

How Bioinformatics is Boosting Precision Medicine

Posted on January 9th, 2017 by in Pharma R&D

Although the pharmaceutical industry has invested a great deal in data-producing technologies (e.g. next-generation and single cell sequencing), it has been slower to invest in the data management and analytics technologies Continue reading “How Bioinformatics is Boosting Precision Medicine” »

  1. 1
  2. 2